Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss-Reference-Cited by-同舟云学术

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

Published:2011-08-01 Issue:3 Volume:204 Page:415-418
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Zoutendijk Roeland,Hansen Bettina E.,van Vuuren Anneke J.,Boucher Charles A. B.,Janssen Harry L. A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/204/3/415/18065728/jir282.pdf

Reference15 articles.

1. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B;Chang;Hepatology,2010

2. Long term (4 year) efficacy and safety of tenofovir disoproxil fumarate (TDF) treatment in HBeAg-positive patients (HBeAg+) with chronic hepatitis B (study 103): preliminary analysis;Heathcote EG;Hepatology,2010

3. Hepatitis B virus infection;Dienstag;N Engl J Med,2008

4. Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients;Moucari;Hepatology,2009

5. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B;Brunetto;Hepatology,2009

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virological markers for clinical trials in chronic viral hepatitis;JHEP Reports;2024-09

2. Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B;Viruses;2024-03-29

3. Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels;Diagnostics;2024-02-25

4. Predictors of therapeutic response to peginterferon α‑2a and nucleos(t)ide analog combination therapy for HBeAg‑negative chronic hepatitis B: 1‑year follow‑up after treatment;Experimental and Therapeutic Medicine;2023-11-03

5. Rapid monophasic HBsAg decline during nucleic-acid polymer–based therapy predicts functional cure;Hepatology Communications;2023-07-17